In non–small-cell lung cancer (NSCLC), the IGF-1R/Tescalcin/c-Src complex mediates the STAT3 pathway to induce ALDH1 expression, which preserves CSC features (Lee et al., 2018). Here, IGF1R is linked to non-small cell lung carcinoma.